Nuclear magnetic resonance in conjunction with functional genomics suggests mitochondrial dysfunction in a murine model of cancer cachexia
about
The Janus-Faced Role of Antioxidants in Cancer Cachexia: New Insights on the Established ConceptsUnderstanding cancer-induced cachexia: imaging the flame and its fuel.Preserved muscle oxidative metabolic phenotype in newly diagnosed non-small cell lung cancer cachexia.The emerging role of skeletal muscle oxidative metabolism as a biological target and cellular regulator of cancer-induced muscle wastingThe role of inflammatory pathways in cancer-associated cachexia and radiation resistance.Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice.Disrupted Skeletal Muscle Mitochondrial Dynamics, Mitophagy, and Biogenesis during Cancer Cachexia: A Role for Inflammation.Mitochondria dysfunction in lung cancer-induced muscle wasting in C2C12 myotubes.Cancer cachexia is associated with a decrease in skeletal muscle mitochondrial oxidative capacities without alteration of ATP production efficiency.Cachexia: a problem of energetic inefficiency.A shared mechanism of muscle wasting in cancer and Huntington's disease.Formoterol attenuates increased oxidative stress and myosin protein loss in respiratory and limb muscles of cancer cachectic rats.Linking Cancer Cachexia-Induced Anabolic Resistance to Skeletal Muscle Oxidative Metabolism.Dysregulation of metabolic-associated pathways in muscle of breast cancer patients: preclinical evaluation of interleukin-15 targeting fatigue.The AMPK agonist 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), but not metformin, prevents inflammation-associated cachectic muscle wasting.
P2860
Q28078802-5A8E0E0A-5100-40B1-8609-DB31BC4B218BQ34138093-881231D1-6E68-404D-A9A7-22782D2041D0Q35690207-3682BEA1-D2C6-438E-8682-151BD9069E3EQ36901945-DD8AE7A3-2734-41C7-A5D2-5BA00E1AA263Q38115997-DA998704-F401-4092-8DEE-BFB8B45C60C0Q38606110-FE22791E-5A9F-47B6-A377-68DC5B63F6C4Q41146515-7B8DA32A-368C-468B-8618-30C97B529F49Q41613604-D7FA3CC3-6B12-4AF1-8914-F6760CCF3E3DQ42350705-4BC8912A-0E75-450B-AE0A-78F4B148E399Q43044556-DA15E2C3-6460-4BF2-AA0D-62FEBEBC603EQ43131306-8EB56E35-3535-48B1-88E1-3849E9EEF4D7Q47130400-1356D4C8-2094-4727-8CFF-0B15D26A10FDQ48155681-C9A8332A-D0F9-4822-8A78-3303252A1513Q52628609-E9D8F72A-2746-4026-AF85-40C990872C41Q55653938-CA6E1880-B352-40D2-A118-A2F11BA82759
P2860
Nuclear magnetic resonance in conjunction with functional genomics suggests mitochondrial dysfunction in a murine model of cancer cachexia
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Nuclear magnetic resonance in ...... urine model of cancer cachexia
@en
Nuclear magnetic resonance in ...... rine model of cancer cachexia.
@nl
type
label
Nuclear magnetic resonance in ...... urine model of cancer cachexia
@en
Nuclear magnetic resonance in ...... rine model of cancer cachexia.
@nl
prefLabel
Nuclear magnetic resonance in ...... urine model of cancer cachexia
@en
Nuclear magnetic resonance in ...... rine model of cancer cachexia.
@nl
P2093
P2860
P50
P356
P1476
Nuclear magnetic resonance in ...... urine model of cancer cachexia
@en
P2093
A Aria Tzika
Cibely Cristine Fontes de Oliveira
Dionyssios Mintzopoulos
Jianxin He
Laurence G Rahme
Meenu Kesarwani
Michael Mindrinos
P2860
P356
10.3892/IJMM.2010.557
P577
2010-11-10T00:00:00Z